Activation of gelatinases by fibrin is PA/plasmin system-dependent in human glomerular endothelial cells

Molecular and Cellular Biochemistry

Volumn 277, Issue 1-2, 2005, Pages 171-179

  Cai, Guangyan ^a   Chen, Xiangmei ^a   Fu, Bo ^a   Lu, Yang ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Endothelial cell; Fibrin; Gelatinase; Plasminogen activators; Zymography

Indexed keywords

APROTININ; CASEIN; FIBRIN; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MESSENGER RNA; PLASMIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME RELEASE; GLOMERULOPATHY; GLOMERULUS; HUMAN; HUMAN CELL; MORPHOLOGY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ZYMOGRAPHY;

BASE SEQUENCE; CELLS, CULTURED; DNA; ENDOTHELIAL CELLS; ENZYME ACTIVATION; FIBRIN; GELATINASES; HUMANS; KIDNEY GLOMERULUS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; METALLOENDOPEPTIDASES; PLASMIN; PLASMINOGEN ACTIVATORS; PLASMINOGEN INACTIVATORS; RNA, MESSENGER;

EID: 24144495591     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11010-005-5995-3     Document Type: Article

References (33)

1. Xu QH, Chen XM, Yu LF: Significance of fibrin related antigen deposition in glomeruli of patients with IgA nephropathy. Chin J Intern Med 35: 140-141, 1996
2. Chen XM, Shi SZ, Lu YJ, Xu QH: Relationship between fibrinogen related antigen deposition and glomerulosclerosis. Chin J Pathophysiol 12: 202-205, 1996
3. 3RGDS interaction mediates fibrin-induced morphological changes of glomerular endothelial cells 56: 1413-1422 1999 10.1046/j.1523-1755.1999.0560041413.x
4. Xu Q, Chen X, Fu B, Ye Y, Yu L: Effects of fibrin on ICAM-1 expression in glomerular endothelial cells. Med J Chin PLA 24: 165-167, 1999
5. Nguyen M, Arkell J, Jackson CJ: Human endothelial gelatinases and angiogenesis. Int J Biochem Cell Biol 33: 960-970, 2001 10.1016/ S1357-2725(01)00007-3
6. Daniel C, Duffield J, Brunner T, Steinmann-Niggli K, Lods N, Marti HP: Matrix metalloproteinase inhibitors cause cell cycle arrest and apoptosis in glomerular mesangial cells. J Pharmacol Exp Ther 297: 57-68, 2001 11259528
7. McMillan JI, Riordan JW, Couser WG, Pollock AS, Lovett DH: Characterization of a glomerular epithelial cell metalloproteinase as matrix metalloproteinase-9 with enhanced expression in a model of membranous nephropathy. J Clin Invest 97: 1094-1101, 1996 8613533
8. Cai GY, Chen XM, Wang ZX, Tian Y, Shi SZ: Aging changes of gelatinase activity in kidney tissue of autoimmune MRL/lpr mice. Chinese J Path 31: 432-435, 2002
9. Woo JH, Lim JH, Kim YH, Suh SI, Min do S, Chang JS, Lee YH, Park JW, Kwon TK: Resveratrol inhibits phorbol myristate acetate-induced matrix metalloproteinase-9 expression by inhibiting JNK and PKC delta signal transduction. Oncogene 23: 1845-1853, 2004 10.1038/sj.onc.1207307
10. Haas TL, Davis SJ, Madri JA: Three-dimensional type I collagen lattices induce coordinate expression of matrix metalloproteinases MT1-MMP and MMP-2 in microvascular endothelial cells. J Biol Chem 273: 3604-3610, 1998 10.1074/jbc.273.6.3604
11. Green DF, Hwang KH, Ryan US: Culture of endothelial cells from baboon and human glomeruli. Kidney Int 41: 1506-1516, 1992 1501407
12. Bator JM, Cohen RL, Chambers DA: A hydrocortisone regulates the dynamics of plasminogen activator and plasminogen activator inhibitor expression in cultured murine keratinocytes. Exp Cell Res 242: 110-119, 1998 10.1006/excr.1998.4065
13. Akao M, Hasebe Y, Okumura N, Hagiwara H, Seki T, Ariga T: Plasminogen activator-plasmin system potentiates the proliferation of hepatocytes in primary culture. Thromb Res 107: 169-174, 2002 10.1016/ S0049-3848(02)00258-X
14. Hertig A, Rondeau E: Role of the coagulation/fibrinolysis system in fibrin-associated glomerular injury. J Am Soc Nephrol 15: 844-853, 2004 10.1097/01.ASN.0000115400.52705.83
15. KamathBS, Lip GY: Fibrinogen: biochemistry, epidemiology and determinants. QJM 96: 711-729, 2003 10.1093/qjmed/hcg129
16. Lenz O, Elliot SJ, Stetler-Stevenson WG: Matrix metalloproteinases in renal development and disease. J Am Soc Nephrol 11: 574-581, 2000 10703682
17. Zucker S, Conner C, Dimassmo BI, Ende H, Drews M, Seiki M, Bahou WF: Thrombin induces the activation of progelatinase A in vascular endothelial cells: Physiologic regulation of angiogenesis, J Biol Chem 270: 23730-23738, 1995 10.1074/jbc.270.40.23730
18. Lenz O, Striker LJ, Jacot TA, Elliot SJ, Killen PD, Striker GE: Glomerular endothelial cells synthesize collagens but little gelatinase A and B. J Am Soc Nephrol 9: 2040-2047, 1998 9808089
19. Eberhardt W, Huwiler A, Beck KF, Walpen S, Pfeilschifter J: Amplification of IL-1 beta-induced matrix metalloproteinase-9 expression by superoxide in rat glomerular mesangial cells is mediated by increased activities of NF-kappa B and activating protein-1 and involves activation of the mitogen-activated protein kinase pathways. J Immunol 165: 5788-5797, 2000 11067938
20. Liu Y, Rajur K, Tolbert E, Dworkin LD: Endogenous hepatocyte growth factor ameliorates chronic renal injury by activating matrix degradation pathways. Kidney Int 58: 2028-2043, 2000 10.1111/j.1523-1755.2000.00375.x
21. Martin J, Eynstone L, Davies M, Steadman R: Induction of metalloproteinases by glomerular mesangial cells stimulated by proteins of the extracellular matrix. J Am Soc Nephrol 12: 88-96, 2001 11134254
22. Kroon ME, van Schie ML, van der Vecht B, van Hinsbergh VW, Koolwijk P: Collagen type 1 retards tube formation by human microvascular endothelial cells in a fibrin matrix. Angiogenesis 5: 257-265, 2002 10.1023/A:1024540701634
23. Aya N, Yoshioka K, Murakami K, Hino S, Okada K, Matsuo O, Maki S: Tissue-type plasminogen activator and its inhibitor in human glomerulonephritis. J Pathol 166: 289-295, 1992 10.1002/path.1711660312
24. Bobik A, Tkachuk V: Metalloproteinases and plasminogen activators in vessel remodeling. Curr Hypertens Rep 5: 466-472, 2003 14594565
25. Lijnen HR: Matrix metalloproteinases and cellular fibrinolytic activity. Biochemistry (Moscow) 67: 92-98, 2002 10.1023/A:1013908332232
26. Rakic JM, Maillard C, Jost M, Bajou K, Masson V, Devy L, Lambert V, Foidart JM, Noel A: Role of plasminogen activator-plasmin system in tumor angiogenesis. Cell Mol Life Sci 60: 463-473, 2003 10.1007/ s000180300039
27. Monea S, Lehti K, Keski-Oja J, Mignatti P: Plasmin activates pro-matrix metalloproteinase-2 with a membrane-type 1 matrix metalloproteinase-dependent mechanism. J Cell Physiol 192: 160-170, 2002 10.1002/jcp.10126
28. Holmbeck K, Bianco P, Yamada S, Birkedal-Hansen H: MT1-MMP: A tethered collagenase. J Cell Physiol 200: 11-19, 2004 10.1002/jcp.20065
29. Ellerbroek SM, Stack MS: Membrane associated matrix metalloproteinases in metastasis. Bioessays 21: 940-949, 1999 10.1002/ (SICI)1521-1878(199911)21:11<940::AID-BIES6>3.0.CO;2-J
30. Ramos-DeSimone N, Hahn-Dantona E, Sipley J, Nagase H, French DL, Quigley JP: Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion. J Biol Chem 274: 13066-13076, 1999 10.1074/jbc.274.19.13066
31. Dudani AK, Ganz PR: Endothelial cell surface actin serves as a binding site for plasminogen, tissue plasminogen activator and lipoprotein(a). Br J Haematol 95: 168-178, 1996 10.1046/j.1365-2141.1996.7482367.x
32. Cai GY, Chen XM, Shi SZ, Huang YM, Tian Y, Wang ZX: Thrombin activation and fibrin deposition in murine lupus nephritis: Inhibitory effects of "shenle" Med J Chin PLA 26: 870-873, 2001
33. Wang J, Chen X, Shi S, Zhang Y, Tian Y: Expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in IgA nephropathy. Chin J Intern Med 41: 75-78, 2002